Cargando…

Association of CYP2D6 genotype predicted phenotypes with oxycodone requirements and side effects in children undergoing surgery

BACKGROUND: Oxycodone is a commonly used oral opioid in children for treating postoperative pain. Highly polymorphic gene CYP2D6 metabolizes oxycodone into its more potent metabolite, oxymorphone. We hypothesized that altered activity due to CYP2D6 polymorphisms will influence oxycodone requirements...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merchant, Soroush, Prows, Cynthia A., Yang, Fang, Ding, Lili, MacDonald, Jacob, Zhang, Xue, Sadhasivam, Senthilkumar, Garcia, Victor, Sturm, Peter, Chidambaran, Vidya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816853/ https://www.ncbi.nlm.nih.gov/pubmed/36618804 http://dx.doi.org/10.21037/atm-2022-58

Ejemplares similares

CYP2D6 Genotype Dependent Oxycodone Metabolism in Postoperative Patients
por: Stamer, Ulrike M., et al.
Publicado: (2013)

DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion
por: Chidambaran, Vidya, et al.
Publicado: (2017)

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
por: Andreassen, Trine Naalsund, et al.
Publicado: (2011)

ABCC3 Genetic Variants are Associated with Postoperative Morphine-induced Respiratory Depression and Morphine Pharmacokinetics in Children
por: Chidambaran, Vidya, et al.
Publicado: (2016)

Evaluation of propofol anesthesia in morbidly obese children and adolescents
por: Chidambaran, Vidya, et al.
Publicado: (2013)

Novel Associations between FAAH Genetic Variants and Postoperative Central Opioid related Adverse Effects
por: Sadhasivam, Senthilkumar, et al.
Publicado: (2015)

A Retrospective Study Comparing Outcomes of Paravertebral Clonidine Infusion for Pediatric Patients Undergoing Nuss Procedure
por: Visoiu, Mihaela, et al.
Publicado: (2023)

Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
por: Kokki, Merja, et al.
Publicado: (2016)

Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers
por: Coyle, D. Tyler, et al.
Publicado: (2020)

Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series
por: Edwards, Andrea, et al.
Publicado: (2021)

Effects of an Oxycodone Conjugate Vaccine on Oxycodone Self-Administration and Oxycodone-Induced Brain Gene Expression in Rats
por: Pravetoni, Marco, et al.
Publicado: (2014)

Protective Effects of Dexmedetomidine and Oxycodone in Patients Undergoing Limb Ischemia-Reperfusion
por: Cheng, Wenjie, et al.
Publicado: (2019)

Novel associations between CYP2B6 polymorphisms, perioperative methadone metabolism and clinical outcomes in children
por: Packiasabapathy, Senthil, et al.
Publicado: (2021)

Cholestatic hepatitis as a possible new side-effect of oxycodone: a case report
por: Ho, Vincent, et al.
Publicado: (2008)

Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model
por: Marsousi, N, et al.
Publicado: (2014)

Economic Study on the Impact of Side Effects in Patients Taking Oxycodone Controlled-Release for Noncancer Pain
por: Anastassopoulos, Kathryn P., et al.
Publicado: (2012)

Effect of preemptive analgesia with intravenous oxycodone in the patients undergoing laparoscopic resection of ovarian tumor
por: Wang, Na, et al.
Publicado: (2015)

Design and implementation of a novel patient-centered empowerment approach for pain optimisation in children undergoing major surgery
por: Chidambaran, Vidya, et al.
Publicado: (2022)

Use of Oxycodone in Pain Management
por: Moradi, Mohammad, et al.
Publicado: (2012)

Epidural Oxycodone for Acute Pain
por: Piirainen, Panu, et al.
Publicado: (2022)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019)

Gender, genetics, and analgesia: understanding the differences in response to pain relief
por: Packiasabapathy, Senthil, et al.
Publicado: (2018)

Incubation of Oxycodone Craving Following Adult-Onset and Adolescent-Onset Oxycodone Self-Administration in Male Rats
por: Altshuler, Rachel D., et al.
Publicado: (2021)

Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats
por: Hinds, Nicole M., et al.
Publicado: (2023)

Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats
por: Hinds, Nicole M., et al.
Publicado: (2023)

Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
por: Deodhar, Malavika, et al.
Publicado: (2021)

Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
por: Qu, Lihui, et al.
Publicado: (2017)

Analgesic efficacy and safety of epidural oxycodone in patients undergoing total hip arthroplasty: a pilot study
por: Olczak, Bogumił, et al.
Publicado: (2017)

Effects of oxycodone on immune function in patients undergoing radical resection of rectal cancer under general anesthesia
por: Cui, Jia-Hua, et al.
Publicado: (2017)

The Effect of Oxycodone on Post-operative Pain and Inflammatory Cytokine Release in Elderly Patients Undergoing Laparoscopic Gastrectomy
por: Lao, Wei-long, et al.
Publicado: (2021)

Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis
por: Lazzari, Marzia, et al.
Publicado: (2015)

Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350
por: Poulsen, Jakob L, et al.
Publicado: (2018)

Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study
por: Webster, Lynn R., et al.
Publicado: (2019)

Current Evidence for Biological Biomarkers and Mechanisms Underlying Acute to Chronic Pain Transition across the Pediatric Age Spectrum
por: Duff, Irina T., et al.
Publicado: (2023)

Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice
por: Ueberall, Michael A, et al.
Publicado: (2016)

Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking
por: Wilkinson, Courtney S., et al.
Publicado: (2023)

Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking
por: Wilkinson, Courtney S., et al.
Publicado: (2023)

Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
por: Qu, Lihui, et al.
Publicado: (2020)

CYP3A4 and CYP3A5 genotyping by Pyrosequencing
por: Garsa, Adam A, et al.
Publicado: (2005)

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing
por: Cavallari, Larisa H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ng9ojo5q2ftnarl5m5jfa2vm36